AND G. TORREGGIANI, M.D. T HE MYOCARDIAL clearance of potassium (MCK) can be measured by means of precordial counting after single intravenous injection of 42KC1 or 86RbCl.1 It may be considered to measure coronary blood flow per unit mass of myocardium under the assumption that the average extraction of the indicator by the myocardium during the first minutes after injection does not differ significantly from the average total body extraction. Theoretical considerations and experimental evidence suggest that these conditions actually occur in rats, dogs, and humans." 2 When a precordial counter is used to measure myocardial radioactivity, the obtained value for MCK represents the mean flow per unit mass, and it is conventionally expressed per 100 g of myocardium.1 Absolute flow cannot be determined with a precordial counter since individual variability in depth and size of the heart prevents an absolute estimate of myocardial uptake of the radioisotope. If the geometric dependence of the measurement could be overcome, coronary blood flow could be estimated as a fraction of cardiac output or in absolute terms. In fact, under conditions of uniform counting efficiency for the entire heart, the fraction of injectate taken up by the myocardium shortly after injection of 86Rb or 42K would equal the fraction of the cardiac output perfusing the myocardium.1 2 The present series of experiments has been designed with the following purposes: (1) From the Medical Clinic and the Center of Nuclear Medicine of the University of Pisa. This work was carried out under the Association Contract Euratom-University of Pisa-U.L.B.-026-63-4-BIAC. 708 to verify the validity of the assumptions underlying the method using 86Rb; (2) to compare t-he results obtained with the precordial counting method with the values of coronary blood flow simultaneously measured with the nitrous oxide method; and (3) to evaluate a counting apparatus designed to reduce the dependence on geometry of the values obtained by counting.
Methods

Measurement of CBF by 86RbC1 Injection Instruments and Operating Conditions
The instrument used for monitoring intracardiac and myocardial radioactivity is shown in figure   1 . It is a twin counter system (TCS*),,3 comprising two Nal scintillation counters (3 by 3 inches), the combined output of which is fed to an amplifier and single-channel pulse-height analyzer. The high voltage supply to the two phototubes is adjusted in order to obtain superposable yspectra from the two detectors. Pulses from the analyzer are fed to a scaler and a linear ratemeter, operating in parallel, and the output of the ratemeter is fed to a DC amplifier of an oscilloscopic recorder.
The scintillation detectors are housed in lead collimators, with cylindrical collimating channels. The crystals are recessed 40 cm in the collimators, and the diameter of the collimating channels can be adjusted from 7.5 to 9 cm. The two collimators are mounted on a movable stand arranged so that the two crystals face each other on the same vertical axis. The lower detector can be positioned under the catheterization table and the distance of the upper detector can be adjusted. This arrangement yields a rather uniform distribution *This instrument was developed as part of the work performed under the sponsorship of the U. S. Atomic Energy Commission, Contract AT( 30-1)-
2648.
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Experimental Procedure
The procedure on the patients is essentially the same as that previously described for precordial counting.' The anteroposterior diameter of the chest at precordial level is measured at the beginning of each study, and the heart silhouette is outlined at fluoroscopy. The TCS is then moved over the heart area, and the distance of the upper counter is adjusted to provide a 30-cm interspace between the ends of the two collimators. As a result, for a chest with an anteroposterior diameter of 20 cm, the two crystals are at the same distance from an ideal plane separating the anterior one third from the posterior two thirds of the chest, assumed to be the central plane for the heart. 1311 as RIHSA (radioiodinated human serum albumin) and 86RbCl are successively injected to measure the intravascular and the intravascular +myocardial precordial radioactivity. The injections are made into the superior vena cava through a polyethylene tube having a total capacity of 0.25 ml, threaded into the median vein through a needle. From a reservoir syringe, 0.2 ml of solution of 86RbCl
Myocardial concentration
Area of primary arterial concentration curve or 131IHSA are transferred into the polyethylene tube, and its proximal end is clamped. Injections are made by flushing the tube with 0.5 ml of saline. This procedure has been found satisfactory for recording radiocardiographic curves.
In some cases, activity equal to that of the injectate was introduced into a 250-ml spheric container enclosed in a Perspex block that was equal in thickness to the anteroposterior diameter of the patient's chest. The counting on the phantom was then carried out with the TCS set up as for counting over the patient (fig. 1 ).
Calculations
Coronary blood flow per 100 g of myocardium was calculated from MCK, as previously described.' The successive steps of the calculations are as follows.
1. The amount of 86Rb extracted by the myocardium in the first 30 seconds after single injection is estimated by subtracting from the precordial counting rate between 30 and 90 seconds the contribution due to intravascular radioactivity. The latter is determined from the precordial counting rate between 30 and 90 seconds after injection of 131IHSA, and the corresponding concentrations of 86Rb and 131IHSA in arterial blood. The geometrical efficiency factors, required to make 131IHSA measurements comparable with 86Rb measurements, are calculated for each case taking into account the anteroposterior diameter of the chest, as shown in the appendix.
The values thus obtained for myocardial 86Rb content equal the product of average myocardial concentration times the effective volume of the myocardium (volume of myocardium times average counting efficiency for it).
2. The area under the 86Rb radiocardiographic curve (RCG) is measured after extrapolation beyond apparent recirculation. This area equals the integral of the primaly arterial concentration curve times the effective volume4 of the heart chambers including any other vessel contributing to the curve (volume of chambers times average counting efficiency for them).
3. Since the effective volumes of myocardium and the heart chambers differ very little from each other' (see also appendix), the ratio of myocardial 86Rb content to area of 86Rb-RCG equals the ratio of myocardial 86Rb concentration to the area of primary arterial concentration curve. 4. Equating volume to mass units for the myocardium, the above ratio gives flow in milliliters per gram of myocardium. In fact, dimensionally, Counts/g of myocardium -Counts/ml of blood x Duration of curve = ml of blood/ g of myocardium/min Circulation, Volume XXXIII, May 1966 which multiplied by 100 gives flow in ml/ 100 g/ min.
Coronary blood flow as a fraction of cardiac output (CBFr) was obtained by dividing the external counting rate due to myocardial activity into the injectate activity measured on the phantom.
Body versus Coronary Extraction
A Goodale Lubin catheter was inserted into the coronary sinus, and a no. 7 Cournand catheter into the right ventricle. The proximal ends of the two catheters and the indwelling brachial artery needle were connected to three syringes mounted on a slightly modified Harvard pump. Injection of the 86RbCl was made into the right branch of the pulmonary artery through a no. 5 Cournand catheter to avoid contamination of the right ventricular blood with primary circulating radioactivity. The connecting tube between the arterial needle and the pump was led through a shielded Nal scintillation counter with a hole drilled in it, and the output of the counter was fed to a ratemeter and recorder. Sampling was started 5 seconds before injection and continued for 90 seconds afterward.
Calcutlations. The average radioactivity concentration in each syringe was equal to
Ft (1) where X and x are respectively the total activity and the mean radioactive concentration in the syringe, F is the rate of withdrawal and t the duration of sampling. The integral represents the area of the concentration curve from beginning to end of sampling. Multiplication of x by t yields this area.
In the record, the primary arterial concentration curve was completed by extrapolation beyond apparent recirculation; its area was then calculated and subtracted from the total area from beginning to end of sampling.
Comparison of the Nitrous Oxide Method with MCK
Coronary blood flow was measured by the nitrous oxide saturation method as modified for the coronary circulation.5 The coronary sinus was cannulated with a Goodale-Lubin catheter. MCK was measured with the usual technique immediately before and after the measurement of coronary blood flow with nitrous oxide.
Studies Performed
Sixty-three patienits were studied: 43 were young subjects with noimal cardiovascular systems; 13 had hypertensive heart disease (HHD) and seven had ischemic heart disease (IHD) without arterial hypertension. The diagnosis had been established on the basis of clinical and electrocardiographic data.
In all cases MCK was measured under basal conditions. In 12 cases (nine normal subjects and three with IHD), a second measurement was performed under the same conditions, from 10 to 20 min after the first one.
In 18 cases (11 normal subjects and seven with HHD), the injectate activity was measured as indicated above for the evalution of fractional CBF, which was then calculated.
In 11 cases (eight normal subjects and three with IHD) N20 measurement of coronary blood flow was performed: in 10 cases between two MCK measurements; in one case, after a single MCK measurement. Finally, in two additional cases the average body extraction was compared with the myocardial extraction.
Results
Coronary Blood Flow Values by the MCK Method
Basal values for MCK averaged 80. 3 + 18.5 (SD) ml/min/100 g of myocardium in the normal group, 56.8 ± 7.0 (SD) ml/min/100 g of myocardium in the HHD group, 46.8 + 4.9 (SD) ml/min/100 g of myocardium in the IHD group. The average values for both HHD and IHD groups differ significantly from the mean normal value (P < 0.001). The distribution of the results obtained is shown in the histograms of figure 2.
Reproducibility of MCK Values
In figure 3 MCK values obtained in two successive measurements performed in the same subject are plotted one against the other. The substantial agreement is evident. The mean difference between the two measurements averages 6.98% of their mean values.
Body versus Myocardial Extraction of 86Rb
The results of the two studies performed are shown in table 1. Average body extraction over the first 90 seconds after injection exceeded myocardial extraction of 6.0% in the average of the two cases. Assuming no loss of indicator in the pulmonary circulationi, of the primary arterial circulation. When calculated in this way, recirculating activity during the first 90 seconds after injection was 34.5% of total arterial activity during the entire period in both cases. This figure compares well with the value of 31% obtained in one case by direct measurement of the primary arterial circulation from the recorded curve, thus confirming the negligible loss of indicator in the pulmonary circulation within the time of observation.
Comparison with the N20 Saturation Method
Coronary blood flow values obtained with the N20 saturation method and those obtained with external counting immediately before and after are reported in table 2 and in figure 4. All the values but one are comprised within the lines of ± 20% deviation from identity. The average values with the N20 and the Circulation, Volume XXXIII, May 1 9G6 86Rb method were 72.0 + 16.8 (SD) and 68.6 ± 16.1 (SD) ml/min/ 100 g of myocardium, respectively.
CBF as Fraction of Cardiac Output
As shown in table 3 CBF was found to represent 5.91+±0.79% of the cardiac output in 11 normal subjects and 6.67 + 1.29% in seven hypertensive subjects. The difference between the two groups did not reach statistical significance.
Discussion
Consideration of the Method
The basic assumption of the present method for the measurement of coronary blood flow is that the fraction of the injected indicator taken up by the myocardium early after injection equals the fraction of the cardiac output perfusing the myocardium.
The validity of this assumption in rats and dogs was shown by Sapirstein,2 and it was explained by the small difference between the average body and myocardial extraction of indicator early after injection.
The actual expression for MCK is: MCK = m(r)/A1 (2) where m(zr) indicates the myocardial concen- Figure 4 unlikely, therefore, that this source of error Comparison of coronary blood flow (CBF) as mea-may be of relevant importance. sured from MCK (86Rb) and the N20 method.
The second set of assumptions deals with the feasibility of using external counting to estimate the myocardial content of indicator.
In the case of the measurement of MCK the relevant assumption is that the "effeCtive volume" contributing counts from the heart cavities and vessels is the same as the "effective volume" contributing counts from the myocardium.1 It has been shown that the difference is contained within narrow limits even for relatively large volumes in case of precordial counting: the conditions are improved further with the TCS which has a much greater uniformity of counting efficiency. In the case of fractional CBF the relevant assumption is that of the adequacy of simulating self-absorption and scattering of radiation within the chest of the patients by counting on Perspex phantoms. Model experiments reported in the appendix suggest that the external counting rate is essentially unaffected by variations in heart size and depth, at least within the range of interest.
These elements, derived from physical considerations and phantom studies, are presently the only ones in support of the latter assumption. However, the significance of the results obtained is an indirect supporting argument that will be examined in the next paragraph.
Considerations of the Results
CBF values per gram of myocardium in normal subjects agree well with previous estimates with the indirect Fick method6 v 8 and with our previous series with precordial detectors.1 The results obtained in the isehemic group agree with the expectancy on the basis of clinical and ECG findings. Data in the hypertensive group also show a significant reduction of CBF per unit heart mass. This latter finding is in agreement with postmortem perfusion studies in hypertrophied hearts,9
and with current knowledge concerning x'ascularization of hypertrophied myocardium. On the other hand, previous studies with N20"'01I have failed to demonstrate reductioni of flow per gram of myocardium in hypertenisive cases. As Gregg and Fisher poinited out, however, limitations inherent in the in-direct Fick method as applied to CBF may account for the results in cardiac hypertrophy. 12, 13 The reproducibility of the measurements appears quite satisfactory in the series examined: it will be noted that the second estimates tend systematically to exceed slightly the first one. No satisfactory explanation is presently available for such tendency.
Comparisons with N20 values, measured during the same study, also seem to be highly satisfactory. The agreement was excellent over the entire range of values explored, from 40 to 110 ml/min/ 100 g myocardium.
Fractional CBF values may be compared only with similar estimates in rats and dogs by Sapirstein.2 CBF in man has been admitted to vary between 5 and 10% of the cardiac output,13 and this is in agreement with the results of some attempts to use the dilution principle to measure CBF. 14 The average values obtained in the groups examined are within this range, but this statement is obviously of limited value. At the moment, no elements are available to validate the significance of our estimates of fractional CBF, but it is nevertheless of some importance that the values be distributed within the range of expectancy.
It should be pointed out that CBF in absolute value and the mass of the heart could be derived from fractional CBF and MCK provided cardiac output is measured at the same time.
Advantages and Disadvantages of the Method
During the last few years a large number of new methods or variants have been proposed for the measurement of coronary blood flow. This probably reflects the inadequacy of currently available methods to meet the requirements for CBF measurement in man.
Precordial measures of myocardial uptake during intravenous infusion of 86Rb have been used by Love and Burchb5 in the attempt to estimate coroniary flow. Difficulties in determining the uptake of the heart alone, separated from surroundinig organis, and the reduction of myocardial extractioni with time' Circulation, Volu-me XXXIII, have prevented development of this approach into a practical technique. Some of the technical difficulties may be overcome by infusing the positron-emitting 84Rb, in place of 86Rb as proposed by Bing and associates.16 This latter method, however, yields a "coronary flow equivalent" which may be of clinical value, but, as pointed out by its authors, it does not represent a procedure for quantitative measurement of coronary flow.
Excluding the methods that demand direct injections in the coronary arteries or in the myocardium, which can be only of limited practical value, the indirect Fick method, with N20, inert radioactive gases or 1311-antipyrine, seems the best available approach. More recently, thermodilution seems to be a promising approach to the problem of directly measuring coronary sinus outflow. '7 An evaluation of the potential merits and disadvantages of the present method in comparison with indirect Fick and thermodilution may be attempted.
The main and immediately evident advantage of the present technic over the other two is the avoidance of coronary sinus catheterization. While this feature may enhance the practical value of the method, its limitation is inherent in the fact that any investigation of myocardial metabolism demands coronary sinus catheterization anyhow. However, insofar as changes in oxygen requirements of the heart are essentially met by changes in flow,18-20 a CBF measurement may be of value per se.
The second unique feature of the present technique is that of measuring the average flow to the entire myocardial mass, independently of the venous drainage. Unperfused areas, which do not contribute to the Fick values since they do not extract the indicator, contribute to the MCK or CBF values by the present method, in which the indicator content of the entire heart is averaged, so that areas with no indicator actually contribute with their zero value to the obtained average. The third, and probably most significant point, is that the-flow value measured by MCK undoubtedly represents actual flow to Circulation, Volume XXXIII, May 1966 true capillaries. The relevance of this feature is best appreciated if considered in the light of the demonstration of arteriovenous anastomotic circuits in the myocardium2' recently confirmed to occur from the arterioles and meta-arterioles to the venules.22 To our knowledge no estimates are presently available of the relative importance of flow shunting circuits in the coronary vascular bed, nor about their modifications in changing states. However, the occurrence of such circuits and the demonstration of nerve endings at the sphincteric structures of the anastomotic vessels22 are suggestive of the potential importance of diversion of flow from true capillaries in the response of the coronary circulation to different stimuli.
Should this flow pattern be of some importance, most of the presently accepted conclusions concerning the physiology, pathophysiology, and pharmacology of the coronary circulation would require reinvestigation, on the basis of a method capable of assessing true capillary flow.
A further advantage of this method in comparison with Kety's technique is its independence from prolonged steady state conditions: the fact that the entire measurement may be completed in 90 seconds is an obvious advantage in comparison with the indirect Fick method, which demands long equilibration periods. Repeatability at time intervals as short as 5 minutes is an important feature that stems from the previous considerations, although from this point of view the method can obviously not compete with thermodilution.
The main present drawback to the method, which also limits its repeatability in the same patient, stems from dosimetric considerations. The small percentage of y-radiations emitted by 86Rb demands the use of relatively large radioactive doses, which limit the number of measurements that may be performed in the individual patient to a maximum of two. The use of 42K cuts down the patient dose by an important factor, but the shortness of its physical half-life makes 42K a somewhat impractical isotope to use.
Geometrical efficiency factors required to make precordial measurements of 1311 radioactivity from RIHSA comparable with 86Rb measurements were calculated by using a Perspex phantom.
The phantom was made up of Perspex slices of variable thickness (0.5 to 1 cm) that could be superimposed to simulate different chest diameters. Spheric containers of variable volumes (100 to 1000 ml) filled with radioactive solution can be included in the Perspex phantom in different positions.
The following experiments were performed counting with the TCS on the phantom:
Effect of Source Volume
The same amount of radioactivity was diluted in water-filled spheric containers of sizes ranging from 100 to 1000 ml, placed at the center of the phantom, the thickness of which along the TCS axis was 20 cm. When the results are expressed as percentage differences from the counting rate for a 100-ml volume, it is seen from figure 5 thbat deviations are always smaller than 5% for both 131I and 86Rb, and smaller than 2.5% up to 700 ml. Changes of TCS counting rate on Perspex phantom for the same amount of activity in spheric containers of increasing size, placed at the center of the phantom, on the counter axis. Changes are expressed as percentage of the counting rate for a 100 ml container. Closed circles, 131I; open circles, 86Rb. 
Effect of Source Depth
The radioactivity-filled spheric containers were counted in the same Perspex phantom, having been placed along the TCS axis but close to one of the surfaces of the phantom (0.5 to 1.5 cm of Perspex between the radioactive container and the phantom surface). When the results are expressed in percentage difference from the counting rates obtained for the same size container in central position, it is seen from figure 6 that the maximal deviation is about 8% for 1311, and about 5% for 86Rb, both occurring for the smallest volumes. For larger volumes, from 200 ml up, deviations are smaller than 5%.
Relative Effect of Chest Thickness on 1311 and 86Rb Counting Two 250-ml spheric containers, filled with 1311 and 86Rb activity of known concentration, were counted in the Perspex block at thicknesses ranging from 17.4 to 22.0 cm, assumed to cover the expected range for anteroposterior chest diameters of adults. Counting was performed with 30-cm interspace between the collimators, as used for in vivo measurements, and with the center of the 250-ml container at the junction of the upper one third with Geometrical efficiency factor (a), required to correct 131I external counting rates for difference in counting efficiency in comparison with 86Rb, counting as a function of the anteroposterior chest diameter, expressed in centimeters. the lower two thirds of the Perspex block. Results were expressed as: 86Rb(TCS) x 131I (well) 86Rb(well) x 1311 (TCS) in which TCS and well, respectively, indicated external counting on phantom and concentration measurement in well counters; a is the factor required to make precordial measurements with 1311 comparable with 86Rb measurements. As represented in figure 7 the values of a show a progressive, although small increase for increasing phantom thickness, due to the progressively greater loss of 131I gammas in respect to the more energetic 86Rb gammas.
Geometrical factors for MCK calculation were derived from this graph in all cases on the basis of anteroposterior chest diameter; frequent controls were made of the constancy of the counting performances of the instruments used for in vivo and in vitro counting.
